Literature DB >> 21527686

Medicine. Shortages of cancer drugs put patients, trials at risk.

Jocelyn Kaiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21527686     DOI： 10.1126/science.332.6029.523

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  14 in total

1.  The drug shortage crisis in the United States: causes, impact, and management strategies.

Authors:  C Lee Ventola
Journal:  P T       Date:  2011-11

2.  Drug shortages pose problems for p&t committees in accountable care organizations.

Authors:  James T O'Donnell; F Randy Vogenberg
Journal:  P T       Date:  2013-07

3.  Getting physical to fix pharma.

Authors:  Patrick R Connelly; T Minh Vuong; Mark A Murcko
Journal:  Nat Chem       Date:  2011-08-23       Impact factor: 24.427

4.  Oncology and the Internet: regulatory failure and reform.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  J Oncol Pract       Date:  2012-07-24       Impact factor: 3.840

Review 5.  ACMT Position Statement on Prescription Drug Shortages.

Authors:  Maryann Mazer-Amirshahi; Erin R Fox; Lewis S Nelson; Silas W Smith; Andrew I Stolbach
Journal:  J Med Toxicol       Date:  2020-04-15

6.  Oncologists' experiences with drug shortages.

Authors:  Kenneth L Kehl; Stacy W Gray; Benjamin Kim; Katherine L Kahn; David Haggstrom; Maryse Roudier; Nancy L Keating
Journal:  J Oncol Pract       Date:  2014-12-30       Impact factor: 3.840

Review 7.  Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy.

Authors:  Yingbo Li; Jie Yang; Xilin Sun
Journal:  Front Chem       Date:  2021-04-22       Impact factor: 5.221

8.  Online availability and safety of drugs in shortage: a descriptive study of internet vendor characteristics.

Authors:  Bryan A Liang; Tim K Mackey
Journal:  J Med Internet Res       Date:  2012-02-09       Impact factor: 5.428

9.  Cellular intrinsic mechanism affecting the outcome of AML treated with Ara-C in a syngeneic mouse model.

Authors:  Wenjun Zhao; Lirong Wei; Dongming Tan; Guangsong Su; Yanwen Zheng; Chao He; Zhengwei J Mao; Timothy P Singleton; Bin Yin
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

Review 10.  Development of biosimilars in an era of oncologic drug shortages.

Authors:  Edward Li; Janakiraman Subramanian; Scott Anderson; Dolca Thomas; Jason McKinley; Ira A Jacobs
Journal:  Drug Des Devel Ther       Date:  2015-06-24       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.